Publications by authors named "K Raemdonck"

Article Synopsis
  • * The review discusses using cationic amphiphilic drugs (CADs) to improve the escape of NAs from endosomes, as they can disrupt cellular membranes and change endosomal pathways.
  • * Repurposing existing CADs, which are commonly used medications, could enhance combination therapies with nucleic acid drugs, potentially increasing their effectiveness.
View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and the third leading cause for cancer-related death worldwide. The tumor is difficult-to-treat due to its inherent resistance to chemotherapy. Antistromal therapy is a novel therapeutic approach, targeting cancer-associated fibroblasts (CAF) in the tumor microenvironment.

View Article and Find Full Text PDF

The delivery of RNA across biological barriers can be achieved by encapsulation in lipid nanoparticles (LNPs). Cationic amphiphilic drugs (CADs) are pharmacologically diverse compounds with ionizable lipid-like features. In this work, we applied CADs as a fifth component of state-of-the-art LNPs via microfluidic mixing.

View Article and Find Full Text PDF

The lung is an attractive target organ for inhalation of RNA therapeutics, such as small interfering RNA (siRNA). However, clinical translation of siRNA drugs for application in the lung is hampered by many extra- and intracellular barriers. We previously developed hybrid nanoparticles consisting of an siRNA-loaded nanosized hydrogel (nanogel) core coated with Curosurf®, a clinically used pulmonary surfactant.

View Article and Find Full Text PDF